J84.841
Neuroendocrine cell hyperplasia of infancy
Clinical Classification Guidelines
Medical Intelligence & Overview
Neuroendocrine cell hyperplasia of infancy (NEHI) is a rare lung disorder that typically affects infants and young children. It involves an abnormal increase in the number of neuroendocrine cells within the lungs, leading to breathing difficulties. This condition is classified under ICD-10 code J84.841. Although the exact cause remains unknown, NEHI generally presents with distinctive symptoms and may require specific diagnostic procedures. Recognizing the signs early can help in managing the condition effectively.
Causes & Symptoms
Clinical Causes: The precise cause of NEHI is currently unknown. Genetic factors might play a role in some cases, but research is ongoing. No clear link to environmental factors or exposures has been established. Most cases appear to be sporadic without a clear family history.
Key Symptoms: Rapid breathing or labored breathing (tachypnea). Persistent cough that may not be specific. Wheezing or abnormal breath sounds. Difficulty feeding or poor weight gain in infants. Recurrent respiratory infections or pneumonia. In some cases, symptoms worsen with activity or during illness.
Diagnostic & Treatment
Diagnosis Path: Diagnosing NEHI usually involves a combination of clinical assessment, imaging, and sometimes biopsy. Key steps include:
Treatment Protocols: There is no specific cure for NEHI, and treatment is primarily supportive. Approaches include:
Clinical Advice & FAQs
Billing Guidance
Is J84.841 a billable ICD-10 code?
Yes, J84.841 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report J84.841?
Clinical documentation must specify the nature of Neuroendocrine cell hyperplasia of infancy and any associated comorbidities for accurate reporting.
Cite this Clinical Reference